Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Milken Institute Center To Study FDA Approval Process, Innovation Strategies

Executive Summary

The Milken Institute's Center for Accelerating Medical Solutions hopes to begin operations in Washington, D.C. during the summer

You may also be interested in...



FDA Efficacy Standard Is Target Of WLF Suit; “Tiered” Approvals Proposed

FDA should grant "initial" approvals based on evidence of efficacy derived from case histories, the Washington Legal Foundation asserts in a lawsuit seeking creation of a tiered drug approval system

FDA Efficacy Standard Is Target Of WLF Suit; “Tiered” Approvals Proposed

FDA should grant "initial" approvals based on evidence of efficacy derived from case histories, the Washington Legal Foundation asserts in a lawsuit seeking creation of a tiered drug approval system

Center for Accelerating Medical Solutions

Former VP Gore staffer Gregory Simon named president of the Milken Institute's newly formed think tank based in D.C. Simon oversaw FDA and NIH programs and the development of a regulatory framework for biotech products while serving as Gore's chief domestic advisor from 1993-1997. He joins CAMS from Infotech Strategies, a D.C.-based consulting firm specializing in health technology and biotech. CAMS will study the FDA approval process and innovation incentives (1"The Pink Sheet" April 14, 2003, p. 4)...

Related Content

UsernamePublicRestriction

Register

PS041615

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel